LAAO Shows Similar Stroke Prevention, Lower Bleeding, Mortality Risk vs. DOACs in AFib, Analysis Shows
Among high-risk atrial fibrillation patients (AF), percutaneous left atrial appendage occlusion (LAAO) with the Amplatzer Amulet device showed a similar rate stroke prevention and lower risk of major bleeding and mortality in comparison with direct oral anticoagulants (DOACs), according to a propensity-matched analysis from the Amulet observational and Danish national patient registries released Monday.